Nm23-H 1/nucleoside diphosphate kinase as a key molecule in breast tumor angiogenesis

Bu Hyun Youn, Hag Dong Kim, Joon Kim

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: Neo-angiogenesis seems to be a critical feature of breast tumor growth, migration and metastasis. Inhibition of angiogenesis may provide information regarding treatment. Since angiogenesis is the result of complex processes, controlled by several angiogenic (pro- and/ or -anti) factors and their receptors, multiple ways to prevent or retrogress tumor-induced angiogenesis have been proposed. The clinically significant activity of bevacizumab and other antiangiogenic treatments have attracted a great deal of interest. Objective/methods: We discuss biological aspects of breast cancer angiogenesis and nucleoside diphosphate kinase (NDPK) as a key molecule in this process. Results/conclusions: In clinical and experimental trials, it was reported that NDPK is inversely related to breast cancer metastasis and angiogenesis. To inhibit the metastatic potential of cancer cells, Nm23-H1/NDP kinase appears to interact with many proteins involved in cellular signal transduction in angiogenesis and tumorigenesis, and therefore reduces the activation of the extracellular signal-regulated kinase (ERK)/MAPK in response to those signals.

Original languageEnglish
Pages (from-to)1419-1430
Number of pages12
JournalExpert Opinion on Therapeutic Targets
Volume12
Issue number11
DOIs
Publication statusPublished - 2008 Nov 1

Fingerprint

Nucleoside-Diphosphate Kinase
Tumors
Breast Neoplasms
Signal transduction
Molecules
Extracellular Signal-Regulated MAP Kinases
Neoplasm Metastasis
Phosphotransferases
Chemical activation
Cells
Signal Transduction
Neoplasms
Carcinogenesis
Clinical Trials
Proteins
Growth

Keywords

  • Angiogenesis
  • Breast cancer
  • Nm23-H1/NDP

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Clinical Biochemistry
  • Molecular Medicine

Cite this

Nm23-H 1/nucleoside diphosphate kinase as a key molecule in breast tumor angiogenesis. / Youn, Bu Hyun; Kim, Hag Dong; Kim, Joon.

In: Expert Opinion on Therapeutic Targets, Vol. 12, No. 11, 01.11.2008, p. 1419-1430.

Research output: Contribution to journalArticle

@article{a1f80e83b1e147f3963468c098181bb9,
title = "Nm23-H 1/nucleoside diphosphate kinase as a key molecule in breast tumor angiogenesis",
abstract = "Background: Neo-angiogenesis seems to be a critical feature of breast tumor growth, migration and metastasis. Inhibition of angiogenesis may provide information regarding treatment. Since angiogenesis is the result of complex processes, controlled by several angiogenic (pro- and/ or -anti) factors and their receptors, multiple ways to prevent or retrogress tumor-induced angiogenesis have been proposed. The clinically significant activity of bevacizumab and other antiangiogenic treatments have attracted a great deal of interest. Objective/methods: We discuss biological aspects of breast cancer angiogenesis and nucleoside diphosphate kinase (NDPK) as a key molecule in this process. Results/conclusions: In clinical and experimental trials, it was reported that NDPK is inversely related to breast cancer metastasis and angiogenesis. To inhibit the metastatic potential of cancer cells, Nm23-H1/NDP kinase appears to interact with many proteins involved in cellular signal transduction in angiogenesis and tumorigenesis, and therefore reduces the activation of the extracellular signal-regulated kinase (ERK)/MAPK in response to those signals.",
keywords = "Angiogenesis, Breast cancer, Nm23-H1/NDP",
author = "Youn, {Bu Hyun} and Kim, {Hag Dong} and Joon Kim",
year = "2008",
month = "11",
day = "1",
doi = "10.1517/14728222.12.11.1419",
language = "English",
volume = "12",
pages = "1419--1430",
journal = "Expert Opinion on Therapeutic Targets",
issn = "1472-8222",
publisher = "Informa Healthcare",
number = "11",

}

TY - JOUR

T1 - Nm23-H 1/nucleoside diphosphate kinase as a key molecule in breast tumor angiogenesis

AU - Youn, Bu Hyun

AU - Kim, Hag Dong

AU - Kim, Joon

PY - 2008/11/1

Y1 - 2008/11/1

N2 - Background: Neo-angiogenesis seems to be a critical feature of breast tumor growth, migration and metastasis. Inhibition of angiogenesis may provide information regarding treatment. Since angiogenesis is the result of complex processes, controlled by several angiogenic (pro- and/ or -anti) factors and their receptors, multiple ways to prevent or retrogress tumor-induced angiogenesis have been proposed. The clinically significant activity of bevacizumab and other antiangiogenic treatments have attracted a great deal of interest. Objective/methods: We discuss biological aspects of breast cancer angiogenesis and nucleoside diphosphate kinase (NDPK) as a key molecule in this process. Results/conclusions: In clinical and experimental trials, it was reported that NDPK is inversely related to breast cancer metastasis and angiogenesis. To inhibit the metastatic potential of cancer cells, Nm23-H1/NDP kinase appears to interact with many proteins involved in cellular signal transduction in angiogenesis and tumorigenesis, and therefore reduces the activation of the extracellular signal-regulated kinase (ERK)/MAPK in response to those signals.

AB - Background: Neo-angiogenesis seems to be a critical feature of breast tumor growth, migration and metastasis. Inhibition of angiogenesis may provide information regarding treatment. Since angiogenesis is the result of complex processes, controlled by several angiogenic (pro- and/ or -anti) factors and their receptors, multiple ways to prevent or retrogress tumor-induced angiogenesis have been proposed. The clinically significant activity of bevacizumab and other antiangiogenic treatments have attracted a great deal of interest. Objective/methods: We discuss biological aspects of breast cancer angiogenesis and nucleoside diphosphate kinase (NDPK) as a key molecule in this process. Results/conclusions: In clinical and experimental trials, it was reported that NDPK is inversely related to breast cancer metastasis and angiogenesis. To inhibit the metastatic potential of cancer cells, Nm23-H1/NDP kinase appears to interact with many proteins involved in cellular signal transduction in angiogenesis and tumorigenesis, and therefore reduces the activation of the extracellular signal-regulated kinase (ERK)/MAPK in response to those signals.

KW - Angiogenesis

KW - Breast cancer

KW - Nm23-H1/NDP

UR - http://www.scopus.com/inward/record.url?scp=56249133012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56249133012&partnerID=8YFLogxK

U2 - 10.1517/14728222.12.11.1419

DO - 10.1517/14728222.12.11.1419

M3 - Article

C2 - 18851697

AN - SCOPUS:56249133012

VL - 12

SP - 1419

EP - 1430

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

SN - 1472-8222

IS - 11

ER -